Page last updated: 2024-08-18

thiophenes and Osteoporosis, Postmenopausal

thiophenes has been researched along with Osteoporosis, Postmenopausal in 221 studies

Research

Studies (221)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (0.90)	18.2507
2000's	114 (51.58)	29.6817
2010's	103 (46.61)	24.3611
2020's	2 (0.90)	2.80

Authors

Authors	Studies
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z	1
Hara, T; Hijikata, Y; Matsubara, Y; Watanabe, N	1
Ammann, P; Béhal, H; Boivin, G; Cortet, B; Falgayrac, G; Farlay, D; Gardegaront, M; Ponçon, C	1
Dong, Q; Li, JY; Li, MH; Liao, NN; Wang, Y	1
Bolland, MJ; Grey, A	2
Ali, MS; Carbonell, C; Martinez-Laguna, D; Prieto-Alhambra, D; Reyes, C; Soria-Castro, A; Tebe, C	1
Chan, CP; Chen, PL; Hsu, RW; Ju, YR; Lin, CY; Pan, WL; Pan, YC	1
Audran, M; Brandi, ML; Bröll, H; Hamdy, NA; Jakob, FJ; McCloskey, EV; Palacios, S	1
Lopez-Picado, A; Mendoza-Edroso, C; Sánchez Garrido-Lestache, N	1
Brzeziańska, E; Cegłowska, A; Liberski, PP; Rieske, P; Sewerynek, E; Stêpień-Kłos, W; Stuss, M	1
Bruyère, O; Pelousse, F; Reginster, JY	1
Huang, J; Kruse, M; Parthan, A; Taylor, D; Viswanathan, HN; Yurgin, N	1
Gallo-Padilla, D; Gallo-Vallejo, JL	1
Brandi, ML; Collette, J; Dawson-Hughes, B; Fardellone, P; Kaufman, JM; Reginster, JY; Rizzoli, R; Vellas, B	1
Borer, JS; Cooper, C; Fox, KM	1
Camargo, MB; Lazaretti-Castro, M; Rocha, OF; Vilaça, T	1
Hviid, A; Pasternak, B; Svanström, H	1
Chen, CH; Chung, WH; Hsiao, HL; Hsiao, YH; Wang, HY; Yang, CY	1
Kurth, A	1
Gosch, M; Kammerlander, C; Nicholas, JA	1
Gambacciani, M; Levancini, M	1
Brown, SL; Cassim, B; Davey, MR; de Lange, W; de Villiers, TJ; Ellis, GC; Hough, FS; Lipschitz, S; Lukhele, M; Pettifor, JM	1
Abboskhujaeva, LS; Alikhanova, NM; Ismailov, SI	1
Basile, G; Catalano, A; Di Stefano, A; Faraci, B; Ientile, R; Lasco, A; Loddo, S; Morabito, N; Morini, E	1
Dullin, C; Ebert, J; Komrakova, M; Sehmisch, S; Stuermer, KM; Tezval, M; Weidemann, A	1
Atteritano, M; Benvenga, S; Catalano, A; Lasco, A; Santoro, D	1
Eiken, P; Vestergaard, P	1
Jędrzejczyk, S; Król, I; Sewerynek, E; Stępień-Kłos, W; Stuss, M	1
Arantes, HP; Bilezikian, JP; Chiang, AY; Gimeno, SG; Lazaretti-Castro, M	1
Kim, YT; Oda, H; Sugiyama, T	1
Crocè, L; di Meo, N; Gubertini, N; Tiribelli, C; Trevisan, G	1
Cao, P; Chen, Y; Deng, L; Guo, L; Hu, B; Hu, J; Ma, J; Shi, C; Tian, Y; Wu, H; Yuan, W; Zhang, Y	1
Balogh, A; Boonen, S; Brandi, ML; Brixen, K; Cormier, C; Delmas, PD; Diez-Perez, A; Felsenberg, D; Goemaere, S; Meunier, PJ; Reginster, JY; Rizzoli, R; Spector, TD	1
Roux, C	2
Arapova, SD; Benevolenskaia, LI; Buklemeshev, IuV; Demin, NV; Dzeranova, LK; Il'in, AV; Korotkova, TA; Marova, EI; Molitvoslovova, NN; Nikitinskaia, OA; Rodionova, SS; Rozhinskaia, LIa; Shumskiĭ, AA; Smirnov, AV; Toroptsova, NV	1
Lee, HY; Lie, D; Lim, KS; Pang, SM; Thirumoorthy, T	1
Boada, A; Carrascosa, JM; Ferrándiz, C; Leal, L	1
Anastasilakis, AD; Avramidis, A; Ballaouri, I; Efstathiadou, Z; Gerou, S; Goulis, DG; Kita, M; Polyzos, SA	1
Andia, JB; Devogelaer, JP; Fechtenbaum, J; Isaia, G; Kolta, S; Roux, C	1
Douglas, I; Grosso, A; Hingorani, A; MacAllister, R; Smeeth, L	1
Lam, S; Zouzias, K	1
Bayhan, I; Ozaksit, G; Ugurlu, N; Uygur, D	1
Chen, JF; Ho, C; Hwang, JS; Su, SL; Tsai, KS; Tu, ST; Wang, CJ; Wu, CH; Wu, DJ; Yang, TS	1
Novak, S	2
Bruyere, O; Hiligsmann, M; Neuprez, A; Reginster, JY; Scholtissen, S	1
Pouilles, JM; Ribot, C; Trémollieres, F	1
Badurski, J; Collette, J; Compston, J; Cormier, C; Diaz-Curiel, M; Isaia, G; Marquis, P; Meunier, PJ; Ortolani, S; Reginster, JY; Roux, C; Wark, JD	1
Doggrell, SA	2
Bruyère, O; Hiligsmann, M; Reginster, JY	2
Arias, LH; Carvajal, A; del Pozo, JG; Sainz, M	1
Abril, N; Cano, A; García-Pérez, MA; Ruiz, C; Tarín, JJ	1
Boonen, S; Bruyère, O; Collette, J; Diaz-Curiel, M; Felsenberg, D; Kaufman, JM; Lorenc, R; Reginster, JY; Spector, TD	1
Chen, JL; Chung, LP; Huang, ML; Hussain, NH; Liu, JM; Meng, XW; Pheng, CS; Sufian, SS; Wai-Chee Kung, A; Wu, YY; Xu, L; Zhang, ZL; Zhu, HM	1
Borgström, F; Coelho, J; Johansson, H; Kanis, JA; McCloskey, E; Oden, A; Ström, O	1
Benhamou, CL; Briot, K; Fechtenbaum, J; Kolta, S; Roux, C; Said-Nahal, R	1
Boivin, G; Delmas, PD; Farlay, D; Jaurand, X; Khebbab, MT; Meunier, PJ	1
Bruyère, O; Devogelaer, JP; Fardellone, P; Reginster, JY; Roberts, A; Roces-Varela, A; Sawicki, A	1
Cortet, B	1
Ferrari, S	1
Ahmet-Camcioglu, N; Durmus-Altun, G; Ekuklu, G; Kucuk, M; Okman-Kilic, T	1
Cox, DA; Downs, RW; Dowsett, SA; Ghosh, A; Harper, K; Moffett, AM	1
Breart, G; Cooper, C; Deltour, N; Meyer, O; Reginster, JY; Speirs, C	1
Bruyère, O; Collette, J; Cormier, C; Decock, C; Detilleux, J; Ortolani, S; Reginster, JY; Rizzoli, R	1
Lewiecki, EM	1
Fratzl, P; Klaushofer, K; Li, C; Paris, O; Paschalis, EP; Roschger, P; Siegel, S	1
Baranova, IA	1
Augat, P; Habermann, B; Kafchitsas, K; Kurth, A; Olender, G	1
Aquino, JP; Benhamou, CL; Boonen, S; Borgström, F; Kaufman, JM; Reginster, JY; Seeman, E; Semler, J; Vellas, B	1
Doherty, JG; Ringe, JD	1
Rabenda, V; Reginster, JY	1
Farrerons, J; Hawkins, F; Ish-Shalom, S; Kapetanos, G; Marín, F; Stepan, J	1
Aye, M; Doherty, SM; Middleton, ET; Steel, SA	2
Shipley, DR; Smith, EV	1
Deeks, ED; Dhillon, S	2
Fratzl, P; Fratzl-Zelman, N; Klaushofer, K; Li, C; Manjubala, I; Meirer, F; Misof, BM; Paschalis, EP; Roschger, P; Simon, R; Streli, C; Zoeger, N	1
Boonen, S	2
Bergmann, P; Body, JJ; Boonen, S; Boutsen, Y; Devogelaer, JP; Goemaere, S; Kaufman, JM; Reginster, JY; Rozenberg, S	1
Colman, A; Dotchin, C; Shanshal, Y	1
Delmas, P; Felsenberg, D; Frieling, I; Krieg, MA; Laroche, M; Rizzoli, R; Thomas, T	1
Amewou-Atisso, M; Christiansen, C; Cox, D; Cummings, SR; McClung, M; Miller, P; Mitlak, B; Powles, T; Reginster, JY; Stock, J; Zanchetta, J	1
Berthelot, JM; Glémarec, J; Guillot, P; Le Goff, B; Maugars, Y	1
Brandi, ML; Felsenberg, D; Marie, PJ	1
Brandi, ML	2
Dixon, T; Gallacher, SJ	1
Eisman, JA; Jönsson, B; Kanis, JA; Papaioannou, A; Siris, ES; Ström, O; Tosteson, A	1
Andersen, HS; Dimai, HP; Gómez-Reino, J; Greisen, H; Muschitz, C; Quesada-Gómez, JM	1
de la Peña, MP; Hawkins, F; Ish-Shalom, S; Kapetanos, G; Kekow, J; Ma, YL; Malouf, J; Marin, F; Martínez, G; Möricke, R; Recker, RR; Stepan, J; Wan, X; Zeng, QQ	1
Johansson, H; Kanis, JA; McCloskey, EV; Oden, A	1
Adamski, H; Chevrant-Breton, J; Colin, F; Dinulescu, M; Grimaud, H; Le Gall, F; Le Merlouette, M	1
Alam, J; Cox, DA; Dowsett, SA; Kendler, DL; Palacios, S; Stock, J; Zanchetta, J	1
Boonen, S; Bréart, G; Cooper, C; Diez-Perez, A; Felsenberg, D; Kanis, JA; Kaufman, JM; Reginster, JY; Rizzoli, R	1
Boivin, G; Doublier, A; Farlay, D; Jaurand, X; Khebbab, MT; Meunier, PJ	1
Bischoff-Ferrari, HA; Buck, G; Perger, L	1
Blake, GM; Fogelman, I	2
Lakatos, P	1
Amling, M; Burghardt, AJ; Busse, B; Hahn, M; Jobke, B; Majumdar, S; Muche, B; Semler, J	1
Weitzmann, MN; Yamaguchi, M	1
Bock, O; Boutroy, S; Chapurlat, RD; Felsenberg, D; Frieling, I; Krieg, MA; Laib, A; Laroche, JM; Rizzoli, R; Thomas, T	1
Lecart, MP; Reginster, JY	1
Gitlin, M; Jick, S; Li, L; Roddam, A; Shearer, A; Shepherd, S; Taylor, A	1
Alam, J; Bhattoa, HP; Cox, DA; Dowsett, SA; Goldstein, SR; Muram, D; Neven, P; Sipos, A	1
García Llopis, P; Martínez Cristóbal, A; Vicente Valor, MI	1
Compston, J	2
Briot, K	1
Stevenson, JC	1
Badurski, J; Balogh, A; Benhamou, CL; Brandi, ML; Bruyère, O; Devogelaer, JP; Diaz-Curiel, M; Felsenberg, D; Goemaere, S; Kaufman, JM; Reginster, JY; Roux, C; Wark, J	1
Przedlacki, J	1
Brincat, M; Erel, CT; Gambacciani, M; Lambrinoudaki, I; Moen, MH; Palacios, S; Rees, M; Rozenberg, S; Schenck-Gustafsson, K; Tremollieres, F; Vujovic, S	1
Chines, AA; Komm, BS	1
Tan, KW; Tay, YK; Wang, YS	1
Christiansen, C; Silverman, S	1
Bouchard, TP; Genuis, SJ	1
Cooper, C; Cortet, B; Diaz-Curiel, M; Kanis, JA; Lorenc, RS; Reginster, JY; Rizzoli, R	1
Adami, S; Buda, S; Cagnoni, C; Degli Esposti, L; Magliaro, C; Minisola, S; Rossini, M; Sinigaglia, L; Veronesi, C	1
Agnusdei, D; Amewou-Atisso, M; Cox, DA; Cummings, SR; Diem, SJ; Dowsett, SA; Fabian, CJ; Muram, D; Neven, P; Powles, TJ; Wickerham, DL	1
Chen, CH; Hwang, JS; Lee, YY; Yang, CH	1
Boivin, G; Doublier, A; Farlay, D	1
Abbas-Chorfa, F; Ambrosi, V; Caillet, P; Chapurlat, R; Jaglal, SB; Reymondier, A; Schott, AM	1
Eriksen, EF; Halse, J; Moen, MH	1
Berköz, M; Comelekoglu, U; Eroglu, P; Sagír, O; Yalin, S	1
Chen, JF; Cheng, MH; Fuh, JL; Lee, WL; Wang, PH	1
Carnevale, V; Cipriani, C; Del Fiacco, R; Fontana, A; Minisola, S; Pepe, J; Romagnoli, E	1
Boivin, G; Doublier, A; Farlay, D; Jaurand, X; Vera, R	1
Jönsson, B; Kanis, JA; Ström, O	1
Calaf Alsina, J; Coronado Martín, PJ	1
Chen, B; Li, Y; Xie, D; Xu, H; Yang, X	1
Reginster, JY	2
Cox, DA; Hurn, PD; Littleton-Kearney, MT; Ostrowski, NL; Rossberg, MI	1
Colette, J; Deroisy, R; Dougados, M; Jupsin, I; Reginster, JY; Roux, C	1
Deroisy, R; Jupsin, I; Reginster, JY	1
Meunier, PJ; Reginster, JY	2
Boivin, G; Meunier, PJ	1
Barlow, D	1
Halkin, V; Lecart, MP; Reginster, JY; Sarlet, N	1
Frey, D; Frey-Rindova, P; Goerres, G; Michel, BA; Uebelhart, D	1
Badurski, JE; Balogh, A; Cannata, J; Genant, HK; Lemmel, EM; Meunier, PJ; Ortolani, S; Pors-Nielsen, S; Reginster, JY; Rizzoli, R; Roux, C; Seeman, E; Spector, TD	1
El-Hajj Fuleihan, G	1
D'Haese, PC; De Broe, ME; Santacruz, F	1
Al-Tureihi, F; Taur, Y; Wolf-Klein, G	1
Alvarez, L; Catalán, MP; De la Piedra, C; García-Moreno, C; Ortiz, A	1
Adami, S; Gatti, D; Viapiana, O	1
Delmas, PD	1
Bass, S; Diamond, T; Ebeling, P; Findlay, D; Flicker, L; MacLennan, A; Markwell, A; Nowson, C; O'Neill, S; Pocock, N; Sambrook, P; Singh, MF	1
Imanishi, Y; Nishizawa, Y	1
Devogelaer, JP; Reginster, JY	1
Parfitt, AM; Riggs, BL	1
Laustsen, G; Wimmett, L	1
Adami, S; Compston, J; Curiel, MD; De Vernejoul, MC; Devogelaer, JP; Felsenberg, D; Goemaere, S; Meunier, PJ; Phenekos, C; Reginster, JY; Sawicki, A; Seeman, E; Sorensen, OH	1
Bruyere, O; Collette, J; Henrotin, Y; Jupsin, I; Reginster, JY; Sarlet, N	1
Lejeune, E; Leonori, L; Reginster, JY; Sarlet, N	1
Christiansen, C; Gambacciani, M; Genazzani, AR; Schneider, HP	1
Mosekilde, L; Nielsen, LR; Vestergaard, P	1
Marie, PJ	3
Eastell, R	1
Rizzoli, R	2
Masaki, H; Miki, T	1
Fottner, C; Weber, MM	1
Adami, S	1
Ortolani, S; Vai, S	1
Burlet, N; Reginster, JY	1
Kendler, DL	1
Doyle, D; Fardellone, P; Fechtenbaum, J; Kolta, S; Luisetto, G; Meunier, PJ; Padrino, JM; Prince, R; Reginster, JY; Roux, C; Sawicki, A; Sorensen, OH; Tulassay, Z	1
Khan, A; Khan, AW	1
Seeman, E	1
Hauser, T; Mazurov, A; Miller, CH	1
Collette, J; Manette, C; Reginster, JY; Sarlet, N; Tancredi, A; Zegels, B	1
Aquino, JP; Benhamou, C; Boonen, S; Brixen, K; Fiore, C; Hoszowski, K; Kaufman, JM; Reginster, JY; Seeman, E; Semler, J; Varela, AR; Vellas, B	1
Adachi, JD; Cranney, A; O'Donnell, S; Reginster, JY; Wells, GA	2
Close, P; Neuprez, A; Reginster, JY	1
Kleerekoper, M	1
Callejas Rubio, JL; López Pérez, L; Ortego Centeno, N; Sánchez Cano, D	1
Borgström, F; Jönsson, B; Kanis, JA; Ström, O	1
Alexandersen, P; Christiansen, C; Karsdal, MA; Qvist, P; Reginster, JY	1
Barna, A; Bourgoin, M; Briot, K; Chapurlat, R; Christin-Maitre, S; Cortet, B; Costagliola, D; Diebolt, V; Dumarcet, N; Lacoin, F; Letombe, B; Nouyrigat, E; Oberlin, F; Orcel, P; Ravaud, P; Roux, C; Seret, P; Thomas, T; Veyries, ML; Vogel, JY; Yoldjian, I	1
Cremers, S; Garnero, P	1
Bilezikian, JP; Girotra, M; Rubin, MR	1
Briot, K; Roux, C; Thomas, T; Trémollières, F	1
Bruyere, O; Malaise, O; Neuprez, A; Reginster, JY	1
Beverley, C; Davis, S; Lloyd-Jones, M; Stevenson, M	1
Rafeiner, P	1
Economopoulos, D; Lyritis, GP; Tournis, S	1
Bors, K	1
Díaz-Curiel, M; Moro Alvarez, MJ	1
Collishaw, S; Huber, C; Mosley, JR; Noble, BS; Reeve, J	1
Jones, G; Powell, S; Winzenberg, T	1
Carlsten, H; Islander, U; Jochems, C; Kallkopf, A; Lagerquist, M; Ohlsson, C	1
Arlot, ME; Burt-Pichat, B; Delmas, PD; Genant, HK; Jiang, Y; Meunier, PJ; Roux, JP; Zhao, J	1
Badurski, J; Cormier, C; de la Loge, C; Diaz-Curiel, M; Isaia, G; Marquis, P; Meunier, PJ; Roux, C; Wark, J	1
Adami, S; Brixen, K; Bruyere, O; Delferriere, D; Devogelaer, JP; Fechtenbaum, J; Kolta, S; Reginster, JY; Roux, C; Spector, T; Wark, JD	1
Badurski, J; Bruyère, O; Cannata, J; de Vernejoul, MC; Detilleux, J; Isaia, G; Ortolani, S; Reginster, JY; Roux, C; Slosman, D	1
Balogh, A; Brixen, K; Devogelaer, JP; Lorenc, R; Reginster, JY; Seeman, E; Spector, T; Stucki, G	1
Alva, D; Cesareo, R; Contini, S; De Rosa, B; Iozzino, M; Lauria, A; Mallardo, L; Napolitano, C; Orsini, A; Reda, G	1
Díez Pérez, A	1
Ohta, H	1
Blahos, J	1
Barnes, L; Casey, M; Groves, C; McMenamin, ME	1
Bilgili, S; Gulhan, I; Gulhan, S; Gunaydin, R; Posaci, C	1
Allain, P; Boivin, G; Boudeulle, M; Deloffre, P; Mauras, Y; Meunier, PJ; Panczer, G; Perrat, B; Tsouderos, Y	1
Rowley, E; Sato, M; Turner, CH; Zeng, GQ	1
Meunier, PJ	1
Albanese, C; Brandi, ML; De Vernejoul, MC; Delmas, PD; Lorenc, R; Meunier, PJ; Pors-Nielsen, S; Reginster, JY; Roces, A; Sebert, JL; Slosman, DO	1

Reviews

89 review(s) available for thiophenes and Osteoporosis, Postmenopausal

Article	Year
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D. The Cochrane database of systematic reviews, 2021, Jul-07, Volume: 7 Topics: Antibodies, Monoclonal; Bias; Bone Density; Bone Density Conservation Agents; Denosumab; Female; Femur Neck; Fractures, Spontaneous; Hip; Humans; Indoles; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Parathyroid Hormone-Related Protein; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Spinal Fractures; Teriparatide; Thiophenes; Watchful Waiting	2021
Safety concerns with the long-term management of osteoporosis. Expert opinion on drug safety, 2013, Volume: 12, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Humans; Osteoporosis, Postmenopausal; Thiophenes	2013
Treatment of osteoporosis in older adults. Panminerva medica, 2014, Volume: 56, Issue:2 Topics: Aged; Aging; Antibodies, Monoclonal, Humanized; Bone Density; Denosumab; Diphosphonates; Female; Frail Elderly; Hormone Replacement Therapy; Humans; Kidney Diseases; Male; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Teriparatide; Thiophenes	2014
Treatment of osteoporosis after alendronate or risedronate. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:1 Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Drug Substitution; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Risedronic Acid; Teriparatide; Thiophenes; Zoledronic Acid	2016
[The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis]. Reumatizam, 2008, Volume: 55, Issue:2 Topics: Bone Density Conservation Agents; Fractures, Spontaneous; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes	2008
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis. Advances in therapy, 2008, Volume: 25, Issue:12 Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Fractures, Bone; Humans; Medication Adherence; Organometallic Compounds; Osteoarthritis; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes	2008
New findings with old drugs for osteoporosis. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:3 Topics: Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Female; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Stroke; Thiophenes	2009
The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis? Climacteric : the journal of the International Menopause Society, 2009, Volume: 12, Issue:4 Topics: Aged; Animals; Bone Density Conservation Agents; Cell Differentiation; Female; Fractures, Bone; Gene Expression Regulation; Humans; Middle Aged; Organometallic Compounds; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Thiophenes	2009
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:2 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Double-Blind Method; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes; Treatment Outcome	2010
Osteoporosis: from early fracture prevention to better bone health with strontium ranelate. Rheumatology (Oxford, England), 2009, Volume: 48 Suppl 4 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes	2009
Continuous broad protection against osteoporotic fractures with strontium ranelate. Rheumatology (Oxford, England), 2009, Volume: 48 Suppl 4 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome	2009
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:6 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Female; Femur Neck; Follow-Up Studies; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Peptide Fragments; Procollagen; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes	2010
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. Journal of women's health (2002), 2009, Volume: 18, Issue:10 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Piperidines; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Vitamin D; Women's Health	2009
[Current approaches to the diagnosis and treatment of postmenopausal osteoporosis]. Terapevticheskii arkhiv, 2009, Volume: 81, Issue:10 Topics: Age Factors; Aged; Algorithms; Body Mass Index; Bone Density; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes	2009
Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat. Rheumatology international, 2010, Volume: 30, Issue:7 Topics: Aged; Bone Density Conservation Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Outcome Assessment, Health Care; Risk Reduction Behavior; Thiophenes; Treatment Outcome	2010
Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:12 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Epidemiologic Methods; Female; Humans; Medication Adherence; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes; Treatment Outcome	2010
Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis. Drugs, 2010, Apr-16, Volume: 70, Issue:6 Topics: Animals; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2010
Addressing the age-related needs of osteoporotic patients with strontium ranelate. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21 Suppl 2 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Bone Density Conservation Agents; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes; Treatment Outcome	2010
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:10 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes	2010
A comparison between bisphosphonates and other treatments for osteoporosis. Current pharmaceutical design, 2010, Volume: 16, Issue:27 Topics: Bone Density Conservation Agents; Diphosphonates; Drug Costs; Drug Monitoring; Female; France; Humans; Male; Medication Adherence; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes	2010
Spotlight on strontium ranelate: in postmenopausal osteoporosis. Drugs & aging, 2010, Sep-01, Volume: 27, Issue:9 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2010
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:6 Topics: Aged; Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes	2011
Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis. Current medical research and opinion, 2010, Volume: 26, Issue:11 Topics: Aged; Bone Density Conservation Agents; Cervical Vertebrae; Diphosphonates; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Thiophenes; Treatment Outcome	2010
Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcified tissue international, 2010, Volume: 87, Issue:6 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; RANK Ligand; Teriparatide; Thiophenes	2010
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:8 Topics: Aged; Aged, 80 and over; Algorithms; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Risk Factors; Spinal Fractures; Thiophenes	2011
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcified tissue international, 2011, Volume: 89, Issue:2 Topics: Bone Density Conservation Agents; Diphosphonates; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Pharmacovigilance; Teriparatide; Thiophenes	2011
[Pharmacologic treatment of osteoporosis--2011]. Orvosi hetilap, 2011, Aug-14, Volume: 152, Issue:33 Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Denosumab; Diphosphonates; Drug Costs; Drug Therapy, Combination; Estrogen Replacement Therapy; Humans; Hungary; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; RANK Ligand; Teriparatide; Thiophenes; Vitamin D	2011
Current options for the management of postmenopausal osteoporosis. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:16 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone; RANK Ligand; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D	2011
[Alopecia areata universalis due to strontium ranelate]. Medicina clinica, 2012, Mar-03, Volume: 138, Issue:5 Topics: Aged, 80 and over; Alopecia Areata; Bone Density Conservation Agents; Drug Therapy, Combination; Female; Humans; Minoxidil; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Vitamins	2012
The use of combination therapy in the treatment of postmenopausal osteoporosis. Endocrine, 2012, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Anabolic Agents; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Thiophenes	2012
Prevention of osteoporosis: one step forward, two steps back. Menopause international, 2011, Volume: 17, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Calcium; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Teriparatide; Thiophenes; Vitamin D	2011
[Strontium ranelate in post-menopausal osteoporosis]. Endokrynologia Polska, 2011, Volume: 62 Suppl 2 Topics: Bone Density; Bone Density Conservation Agents; Bone Resorption; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Randomized Controlled Trials as Topic; Thiophenes	2011
EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis. Maturitas, 2012, Volume: 71, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Thiophenes	2012
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas, 2012, Volume: 71, Issue:3 Topics: Bone Density Conservation Agents; Breast; Endometrium; Female; Fractures, Bone; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes	2012
Individualizing osteoporosis therapy. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:3 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Precision Medicine; Teriparatide; Thiophenes	2012
Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Current medical research and opinion, 2012, Volume: 28, Issue:3 Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Risedronic Acid; Thiophenes; Vitamin D	2012
New developments in the treatment of osteoporosis. Acta obstetricia et gynecologica Scandinavica, 2013, Volume: 92, Issue:6 Topics: Algorithms; Anorexia; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Calcium, Dietary; Decision Making; Denosumab; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Hyperparathyroidism, Secondary; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Practice Guidelines as Topic; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D; Vitamin D Deficiency	2013
Osteoporosis treatment in postmenopausal women with pre-existing fracture. Taiwanese journal of obstetrics & gynecology, 2012, Volume: 51, Issue:2 Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes	2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action]. Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism	2013
Strontium ranelate in osteoporosis. Current pharmaceutical design, 2002, Volume: 8, Issue:21 Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Calcium; Cell Differentiation; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Models, Animal; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes; Tissue Distribution	2002
Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS drug reviews, 2002,Fall, Volume: 8, Issue:3 Topics: Animals; Breast Neoplasms; Cardiovascular System; Central Nervous System; Cognition; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Hypothalamo-Hypophyseal System; Male; Neuroprotective Agents; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Receptors, Neurotransmitter; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus	2002
Strontium ranelate: a new paradigm in the treatment of osteoporosis. Drugs of today (Barcelona, Spain : 1998), 2003, Volume: 39, Issue:2 Topics: Animals; Biological Availability; Bone and Bones; Disease Models, Animal; Female; Humans; Male; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes; Tissue Distribution	2003
The mineralization of bone tissue: a forgotten dimension in osteoporosis research. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14 Suppl 3 Topics: Animals; Bone Density; Bone Remodeling; Bone Resorption; Calcium; Female; Haplorhini; Humans; Male; Minerals; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2003
Management of post-menopausal osteoporosis: something new on the horizon? Journal of endocrinological investigation, 2003, Volume: 26, Issue:2 Topics: Bone Remodeling; Calcium; Diphosphonates; Female; Hormone Replacement Therapy; Humans; Male; Organometallic Compounds; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes; Vitamin D	2003
[Prevention of hip fractures in the elderly: where are we in 2003?]. Revue medicale de Liege, 2003, Volume: 58, Issue:4 Topics: Aged; Calcitonin; Calcium; Dietary Supplements; Diphosphonates; Estrogen Replacement Therapy; Female; Hip Fractures; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D	2003
[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium]. Zeitschrift fur Rheumatologie, 2003, Volume: 62, Issue:6 Topics: Aged; Bone Density; Clinical Trials as Topic; Diphosphonates; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Treatment Outcome	2003
Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16 Suppl 1 Topics: Aged; Bone Resorption; Calcium, Dietary; Dietary Supplements; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes; Uncoupling Agents; Vitamin D	2005
Clinical effects of strontium ranelate in women with postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16 Suppl 1 Topics: Aged; Clinical Trials, Phase III as Topic; Diarrhea; Female; Fractures, Bone; Gastritis; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Risk; Spinal Fractures; Thiophenes; Uncoupling Agents	2005
[Strontium Ranelate as a new therapeutic agent for osteoporosis]. Clinical calcium, 2005, Volume: 15, Issue:1 Topics: Bone Density; Bone Resorption; Clinical Trials as Topic; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Thiophenes	2005
[Treatment of postmenopausal osteoporosis in 2004]. Revue medicale de Liege, 2004, Volume: 59, Issue:11 Topics: Aged; Calcium; Diphosphonates; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone-Related Protein; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D	2004
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:2 Topics: Adult; Age Factors; Aged; Aging; Anabolic Agents; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Bone Resorption; Female; Humans; Middle Aged; Models, Biological; Norpregnenes; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Terminology as Topic; Testosterone; Thiophenes; Time Factors	2005
2004 drug approval highlights: FDA update. The Nurse practitioner, 2005, Volume: 30, Issue:2 Topics: Administration, Cutaneous; Amlodipine; Anti-Bacterial Agents; Antidepressive Agents; Bronchodilator Agents; Cardiovascular Agents; Drug Approval; Drug Combinations; Duloxetine Hydrochloride; Eplerenone; Estradiol; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Agents; Heptanoic Acids; Humans; Ketolides; Male; Memantine; Osteoporosis, Postmenopausal; Pyrroles; Rifamycins; Rifaximin; Scopolamine Derivatives; Spironolactone; Thiophenes; Tiotropium Bromide; United States	2005
Strontium as therapy for osteoporosis. Current opinion in pharmacology, 2005, Volume: 5, Issue:6 Topics: Animals; Bone Density; Bone Diseases, Metabolic; Humans; Organometallic Compounds; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes	2005
A new treatment for post-menopausal osteoporosis: strontium ranelate. Journal of endocrinological investigation, 2005, Volume: 28, Issue:8 Suppl Topics: Bone and Bones; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2005
[How to take charge of osteoporosis in women in 2005]. Revue de l'infirmiere, 2005, Issue:115 Topics: Absorptiometry, Photon; Cost of Illness; Diphosphonates; Female; Fractures, Bone; France; Humans; Life Style; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Primary Prevention; Risk Assessment; Risk Factors; Risk Reduction Behavior; Selective Estrogen Receptor Modulators; Thiophenes; Women's Health	2005
[Strontium ranelate]. Clinical calcium, 2006, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Bone Resorption; Clinical Trials as Topic; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2006
[The latest developments in endocrinology 2004/2005]. Medizinische Klinik (Munich, Germany : 1983), 2006, Jan-15, Volume: 101, Issue:1 Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed	2006
Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone, 2006, Volume: 38, Issue:2 Suppl 1 Topics: Animals; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Fractures, Bone; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Restraint, Physical; Thiophenes	2006
Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages. Bone, 2006, Volume: 38, Issue:2 Suppl 1 Topics: Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Clinical Trials, Phase III as Topic; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes	2006
Strontium ranelate: the first dual acting treatment for postmenopausal osteoporosis. Clinical orthopaedics and related research, 2006, Volume: 443 Topics: Animals; Bone Density; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2006
Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action. Current osteoporosis reports, 2006, Volume: 4, Issue:1 Topics: Animals; Bone and Bones; Female; Hip Fractures; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes; Treatment Outcome	2006
Strontium ranelate for osteoporosis? Drug and therapeutics bulletin, 2006, Volume: 44, Issue:4 Topics: Aged; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2006
Anabolic agents: a new chapter in the management of osteoporosis. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2006, Volume: 28, Issue:2 Topics: Anabolic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Fluorides; Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organometallic Compounds; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes	2006
Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review. Current opinion in rheumatology, 2006, Volume: 18 Suppl 1 Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Female; Fractures, Bone; Health Status; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Severity of Illness Index; Thiophenes; Treatment Outcome	2006
Selective alpha7 nicotinic acetylcholine receptor ligands. Current medicinal chemistry, 2006, Volume: 13, Issue:13 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bone and Bones; Disease Models, Animal; Female; Humans; Ligands; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Receptors, Nicotinic; Thiophenes	2006
Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate. Current medicinal chemistry, 2006, Volume: 13, Issue:13 Topics: Animals; Bone and Bones; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes	2006
Strontium ranelate for preventing and treating postmenopausal osteoporosis. The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3 Topics: Bone Density; Bone Density Conservation Agents; Diarrhea; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes	2006
Developments in the pharmacotherapeutic management of osteoporosis. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Carrier Proteins; Cathepsin K; Cathepsins; Denosumab; Diphosphonates; Drug Administration Schedule; Female; Hip Fractures; Humans; Membrane Glycoproteins; Meta-Analysis as Topic; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Protease Inhibitors; Randomized Controlled Trials as Topic; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Selective Estrogen Receptor Modulators; Spinal Fractures; Teriparatide; Thiophenes	2006
Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2006, Volume: 17, Issue:12 Topics: Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes	2006
[Drug treatment of postmenopausal osteoporosis. What's New in 2006]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2 Topics: Absorptiometry, Photon; Adult; Age Factors; Aged; Aged, 80 and over; Alendronate; Body Mass Index; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Femoral Fractures; Follow-Up Studies; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Raloxifene Hydrochloride; Risk Factors; Spinal Fractures; Tablets; Teriparatide; Thiophenes; Time Factors	2006
Strontium ranelate for preventing and treating postmenopausal osteoporosis. The Cochrane database of systematic reviews, 2006, Oct-18, Issue:4 Topics: Bone Density; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes	2006
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls. Drugs, 2006, Volume: 66, Issue:16 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Neoplasms; Bone Remodeling; Bone Resorption; Calcitonin; Cathepsin K; Cathepsins; Collagen Type I; Denosumab; Diphosphonates; Drug Administration Schedule; Drug Design; Female; Humans; Organometallic Compounds; Osteitis Deformans; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; RANK Ligand; Thiophenes	2006
Anabolic skeletal therapy for osteoporosis. Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:4 Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Female; Fractures, Bone; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Risk Factors; Teriparatide; Thiophenes	2006
How long should patients take medications for postmenopausal osteoporosis? Joint bone spine, 2007, Volume: 74, Issue:1 Topics: Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Drug Administration Schedule; Drug Monitoring; Etidronic Acid; Female; Fractures, Spontaneous; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Risedronic Acid; Risk Assessment; Teriparatide; Thiophenes; Time Factors; Treatment Outcome	2007
Strontium ranelate in the prevention of osteoporotic fractures. International journal of clinical practice, 2007, Volume: 61, Issue:2 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Diarrhea; Female; Humans; Middle Aged; Nausea; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2007
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women. Health technology assessment (Winchester, England), 2007, Volume: 11, Issue:4 Topics: Cost-Benefit Analysis; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome; United Kingdom	2007
[Osteoporosis: basics and pitfalls]. Praxis, 2007, Jan-24, Volume: 96, Issue:4 Topics: Absorptiometry, Photon; Aged; Diphosphonates; Estrogen Receptor Modulators; Female; Fractures, Spontaneous; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Practice Guidelines as Topic; Primary Health Care; Risk Factors; Thiophenes	2007
Strontium ranelate: a novel treatment in postmenopausal osteoporosis. Annals of the New York Academy of Sciences, 2006, Volume: 1092 Topics: Clinical Trials as Topic; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2006
[Up-to-date treatments for osteoporosis]. Orvosi hetilap, 2006, Feb-19, Volume: 147, Issue:7 Topics: Bone Density; Bone Density Conservation Agents; Bone Regeneration; Calcitonin; Calcium Compounds; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Fluorides; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Testosterone; Thiophenes; Vitamin D	2006
Pharmacological treatment of osteoporosis for people over 70. Aging clinical and experimental research, 2007, Volume: 19, Issue:3 Topics: Aged; Alendronate; Bone Density; Calcitonin; Calcium; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Ibandronic Acid; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Risedronic Acid; Thiophenes; Vitamin D	2007
Strontium ranelate--does it affect the management of postmenopausal osteoporosis? Australian family physician, 2007, Volume: 36, Issue:8 Topics: Aged; Aged, 80 and over; Bone Density; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Thiophenes	2007
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy. Clinical interventions in aging, 2006, Volume: 1, Issue:4 Topics: Bone Density; Female; Hip Fractures; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Spine; Thiophenes; Treatment Outcome	2006
Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures. Minerva endocrinologica, 2007, Volume: 32, Issue:4 Topics: Alendronate; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Female; Fractures, Bone; Humans; Ibandronic Acid; Organometallic Compounds; Osteoporosis, Postmenopausal; Risedronic Acid; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D	2007
[Status of novel bone-targeting SERMs in development]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Nov-28, Volume: 65 Suppl 9 Topics: Animals; Bone and Bones; Bone Density; Clinical Trials as Topic; Drug Design; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Receptors, Estrogen; Research; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes	2007
Treatment and prevention of osteoporosis. Wiener medizinische Wochenschrift (1946), 2007, Volume: 157, Issue:23-24 Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium, Dietary; Combined Modality Therapy; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Exercise; Humans; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D	2007
[Strontium ranlelate (Protelos)]. Revue medicale de Liege, 2007, Volume: 62, Issue:11 Topics: Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2007
[Strontium ranelate (Osseor)--unique double mechanism--physiologic bone treatment as live tissue]. Reumatizam, 2007, Volume: 54, Issue:2 Topics: Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes	2007
Anabolic agents for treating postmenopausal osteoporosis. Joint bone spine, 2001, Volume: 68, Issue:6 Topics: Animals; Controlled Clinical Trials as Topic; Female; Fluorides; Fractures, Spontaneous; Growth Hormone; Humans; Insulin-Like Growth Factor I; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Simvastatin; Thiophenes	2001

Trials

46 trial(s) available for thiophenes and Osteoporosis, Postmenopausal

Article	Year
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:5 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Cholecalciferol; Combined Modality Therapy; Dietary Supplements; Diphosphonates; Female; Gene Expression Regulation; Humans; Ibandronic Acid; Leukocytes, Mononuclear; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; RNA, Messenger; Thiophenes	2013
Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients. European journal of endocrinology, 2014, Volume: 170, Issue:3 Topics: Aged; Cholecalciferol; Female; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Strontium; Thiophenes; Vitamin D; Vitamin D Deficiency	2014
Efficacy of strontium ranelate in combination with a D-hormone analog for the treatment of postmenopausal osteoporosis. Drugs in R&D, 2014, Volume: 14, Issue:4 Topics: Accidental Falls; Aged; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Middle Aged; Motor Skills; Osteoporosis, Postmenopausal; Peptide Fragments; Procollagen; Thiophenes	2014
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis and rheumatism, 2008, Volume: 58, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Double-Blind Method; Female; Fractures, Bone; Hip Fractures; Humans; Longitudinal Studies; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Injuries; Thiophenes; Treatment Outcome	2008
[Efficacy and safety of bivalos therapy for postmenopausal osteoporosis. Results of Russian multicenter trial]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:5 Topics: Absorptiometry, Photon; Administration, Oral; Aged; Bone Density; Bone Density Conservation Agents; Cytokines; Dose-Response Relationship, Drug; Female; Femur; Humans; Immunoenzyme Techniques; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2008
No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial. Clinical endocrinology, 2009, Volume: 70, Issue:4 Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Calcium; Collagen Type I; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Peptides; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D	2009
Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis. Annals of the rheumatic diseases, 2008, Volume: 67, Issue:12 Topics: Aged; Body Mass Index; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Radiography; Spinal Fractures; Thiophenes; Treatment Outcome	2008
The effects of strontium ranelate in Asian women with postmenopausal osteoporosis. Calcified tissue international, 2008, Volume: 83, Issue:5 Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcium; Double-Blind Method; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Taiwan; Thiophenes; Vitamin D	2008
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2009, Volume: 20, Issue:10 Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Administration Schedule; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; Spinal Fractures; Thiophenes; Treatment Outcome	2009
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:1 Topics: Aged; Aged, 80 and over; Belgium; Bone Density; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Administration Schedule; Epidemiologic Methods; Female; Health Care Costs; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality-Adjusted Life Years; Thiophenes	2010
Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis. Bone, 2009, Volume: 45, Issue:3 Topics: Aged; Asian People; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2009
In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:4 Topics: Aged; Biopsy; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Dose-Response Relationship, Drug; Double-Blind Method; Electron Probe Microanalysis; Female; Humans; Ilium; Microradiography; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2010
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Bone, 2009, Volume: 45, Issue:6 Topics: Aged; Bone Density; Bone Density Conservation Agents; Female; Femur Neck; Fractures, Bone; Hip; Humans; Incidence; Lumbar Vertebrae; Organometallic Compounds; Osteoporosis, Postmenopausal; Patient Compliance; Thiophenes; Time Factors	2009
Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:7 Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Female; Humans; Lipids; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Vasomotor System	2010
Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Bone, 2010, Volume: 46, Issue:4 Topics: Aged, 80 and over; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Female; Hip Fractures; Humans; Intention to Treat Analysis; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Spinal Fractures; Thiophenes; Treatment Outcome	2010
The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:3 Topics: Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Regeneration; Bone Resorption; Diphosphonates; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Time Factors	2010
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis. Rheumatology international, 2010, Volume: 30, Issue:10 Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Female; Femur Neck; Fractures, Bone; Hip Joint; Humans; Middle Aged; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Spine; Thiophenes; Tibia; Tomography, X-Ray Computed	2010
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Thiophenes	2011
The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:9 Topics: Austria; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Female; Humans; Middle Aged; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Quality of Life; Spain; Thiophenes; Treatment Outcome	2011
Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis. Bone, 2011, May-01, Volume: 48, Issue:5 Topics: Biopsy; Bone Density Conservation Agents; Female; Humans; Ilium; Organometallic Compounds; Osteoporosis, Postmenopausal; Periosteum; Teriparatide; Thiophenes	2011
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:1 Topics: Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Hip Joint; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Retreatment; Spine; Thiophenes; Treatment Outcome	2012
Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:3 Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Double-Blind Method; Female; Femur Neck; Hip Joint; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Thiophenes; Treatment Outcome	2012
Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate. European journal of endocrinology, 2011, Volume: 165, Issue:3 Topics: Aged; Biopsy; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Electron Probe Microanalysis; Female; Humans; Ilium; Organometallic Compounds; Osteoporosis, Postmenopausal; Strontium; Thiophenes	2011
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:1 Topics: Aged; Alendronate; Bone and Bones; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Female; Femur Neck; Finite Element Analysis; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Radius; Thiophenes; Tibia; Tomography, X-Ray Computed	2012
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; Female; Genital Diseases, Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Uterine Hemorrhage; Vaginitis; Vulvitis	2012
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:3 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Administration Schedule; Female; Femur Neck; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes; Time Factors; Treatment Outcome	2012
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene. Breast cancer research and treatment, 2012, Volume: 134, Issue:1 Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Double-Blind Method; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Risk Factors; Thiophenes	2012
Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:3 Topics: Aged; Aged, 80 and over; Apatites; Biopsy; Bone and Bones; Bone Density Conservation Agents; Crystallization; Double-Blind Method; Female; Humans; Ilium; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; X-Ray Diffraction	2013
Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:12 Topics: Analysis of Variance; Biomarkers; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2002
Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14 Suppl 3 Topics: Aged; Calcium; Double-Blind Method; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Prospective Studies; Research Design; Thiophenes; Treatment Outcome; Vitamin D	2003
Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14 Suppl 3 Topics: Aged; Analysis of Variance; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Treatment Outcome	2003
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. The New England journal of medicine, 2004, Jan-29, Volume: 350, Issue:5 Topics: Administration, Oral; Aged; Biomarkers; Biopsy; Bone and Bones; Bone Density; Calcium; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Femur Neck; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Prospective Studies; Radiography; Risk; Secondary Prevention; Spinal Fractures; Strontium; Thiophenes; Thoracic Vertebrae; Treatment Outcome	2004
Recent important clinical trials of drugs in osteoporosis. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:7 Topics: Aged; Alendronate; Animals; Calcitriol; Drug Therapy, Combination; Exercise Therapy; Female; Heart Transplantation; Humans; Meta-Analysis as Topic; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Assessment; Thiophenes	2004
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:5 Topics: Aged; Aged, 80 and over; Bone Density; Double-Blind Method; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes	2005
Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action. Current osteoporosis reports, 2005, Volume: 3, Issue:1 Topics: Animals; Double-Blind Method; Female; Humans; In Vitro Techniques; Organometallic Compounds; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; Prospective Studies; Rats; Spinal Fractures; Thiophenes	2005
Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis. Bone, 2006, Volume: 38, Issue:2 Suppl 1 Topics: Aged; Bone Density Conservation Agents; Bone Resorption; Female; Hip Fractures; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Risk Factors; Spinal Fractures; Thiophenes	2006
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2006, Volume: 21, Issue:4 Topics: Bone Density; Double-Blind Method; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Spinal Fractures; Thiophenes	2006
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2006, Volume: 21, Issue:7 Topics: Age Factors; Aged; Aged, 80 and over; Double-Blind Method; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Retrospective Studies; Risk Factors; Spinal Fractures; Spine; Thiophenes	2006
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone, 2007, Volume: 40, Issue:1 Topics: Biomarkers; Cartilage; Clinical Trials, Phase III as Topic; Collagen Type II; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Postmenopause; Thiophenes	2007
Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2008, Volume: 23, Issue:2 Topics: Aged; Biopsy; Bone Remodeling; Double-Blind Method; Female; Histocytochemistry; Humans; Ilium; Middle Aged; Organometallic Compounds; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Postmenopause; Thiophenes; Time; Tomography, X-Ray Computed	2008
Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:4 Topics: Adult; Bone Density; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Spinal Fractures; Thiophenes; Treatment Outcome	2008
Effects of strontium ranelate on spinal osteoarthritis progression. Annals of the rheumatic diseases, 2008, Volume: 67, Issue:3 Topics: Aged; Back Pain; Bone Density Conservation Agents; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Osteoarthritis; Osteoporosis, Postmenopausal; Severity of Illness Index; Spinal Diseases; Thiophenes; Treatment Outcome	2008
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2008, Volume: 23, Issue:3 Topics: Aged; Aged, 80 and over; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Prevalence; Risk Factors; Spinal Fractures; Spine; Thiophenes; Time Factors	2008
The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study. Archives of gynecology and obstetrics, 2008, Volume: 278, Issue:5 Topics: Adult; Age Factors; Aged; Body Mass Index; Bone Density; Bone Density Conservation Agents; Female; Follow-Up Studies; Humans; Insulin-Like Growth Factor I; Leptin; Middle Aged; Organometallic Compounds; Osteocalcin; Osteoporosis, Postmenopausal; Prospective Studies; Thiophenes	2008
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:5 Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density; Collagen; Collagen Type I; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Peptides; Placebos; Safety; Thiophenes; Treatment Outcome	2002

Other Studies

87 other study(ies) available for thiophenes and Osteoporosis, Postmenopausal

Article	Year
Bone matrix quality in paired iliac bone biopsies from postmenopausal women treated for 12 months with strontium ranelate or alendronate. Bone, 2021, Volume: 153 Topics: Alendronate; Biopsy; Bone Density; Bone Density Conservation Agents; Bone Matrix; Female; Humans; Ilium; Osteoporosis, Postmenopausal; Postmenopause; Thiophenes	2021
[Changes of TGF-β1 expression during orthodontic tooth movement in rats with osteoporosis]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2017, Volume: 26, Issue:1 Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Humans; Male; Molar; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Periodontium; Rats; Rats, Sprague-Dawley; Thiophenes; Tooth Movement Techniques; Transforming Growth Factor beta1	2017
Cessation of strontium ranelate supply. BMJ (Clinical research ed.), 2017, 05-26, Volume: 357 Topics: Bone Density Conservation Agents; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2017
One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2017, Volume: 28, Issue:10 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Databases, Factual; Denosumab; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Sensitivity and Specificity; Social Class; Spain; Teriparatide; Thiophenes	2017
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report. Clinical interventions in aging, 2017, Volume: 12 Topics: Aged, 80 and over; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Osteoporosis, Postmenopausal; Postmenopause; Thiophenes	2017
A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years. Rheumatology international, 2013, Volume: 33, Issue:9 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Cohort Studies; Europe; Female; Follow-Up Studies; Humans; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Retrospective Studies; Thiophenes	2013
[Postmenopausal osteoporosis: Primary prevention or excessive use of medications]. Semergen, 2013, Volume: 39, Issue:3 Topics: Aged; Cross-Sectional Studies; Diphosphonates; Drug Utilization; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Primary Prevention; Raloxifene Hydrochloride; Thiophenes	2013
Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US. Applied health economics and health policy, 2013, Volume: 11, Issue:5 Topics: Aged; Aged, 80 and over; Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cost-Benefit Analysis; Denosumab; Diphosphonates; Drug Costs; Etidronic Acid; Female; Health Care Costs; Humans; Insurance, Health, Reimbursement; Markov Chains; Osteoporosis, Postmenopausal; Risedronic Acid; Sweden; Thiophenes; United States	2013
[As regards "Post-menopausal osteoporosis: primary prevention or excessive medication"]. Semergen, 2014, Volume: 40, Issue:2 Topics: Diphosphonates; Drug Utilization; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Primary Prevention; Raloxifene Hydrochloride; Thiophenes	2014
Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014, Volume: 25, Issue:2 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Databases, Factual; Female; Hospitalization; Humans; Middle Aged; Myocardial Infarction; Osteoporosis, Postmenopausal; Thiophenes; United Kingdom	2014
Vitamin D supplementation and strontium ranelate absorption in postmenopausal women with low bone mass. European journal of endocrinology, 2014, Volume: 170, Issue:4 Topics: Aged; Area Under Curve; Bone Density Conservation Agents; Calcium; Case-Control Studies; Cholecalciferol; Female; Humans; Intestinal Absorption; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Thiophenes; Vitamin D; Vitamin D Deficiency; Vitamins	2014
Use of strontium ranelate and risk of acute coronary syndrome: cohort study. Annals of the rheumatic diseases, 2014, Volume: 73, Issue:6 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Cohort Studies; Denmark; Diphosphonates; Etidronic Acid; Female; Humans; Ibandronic Acid; Middle Aged; Osteoporosis, Postmenopausal; Proportional Hazards Models; Risedronic Acid; Thiophenes	2014
Strontium ranelate related Stevens-Johnson syndrome: a case report. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014, Volume: 25, Issue:6 Topics: Aged; Bone Density Conservation Agents; Drug Eruptions; Female; Humans; Osteoporosis, Postmenopausal; Stevens-Johnson Syndrome; Thiophenes	2014
[Impacts on bone mineral density]. Der Orthopade, 2014, Volume: 43, Issue:2 Topics: Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Diphosphonates; Durapatite; Extracellular Space; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2014
Management of postmenopausal osteoporosis and the prevention of fractures. Panminerva medica, 2014, Volume: 56, Issue:2 Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Hormone Replacement Therapy; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Phytoestrogens; Radiography; Risk Factors; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Treatment Outcome	2014
The safety of osteoporosis medication. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2014, Volume: 104, Issue:4 Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Calcitonin; Calcium; Cardiovascular Diseases; Constipation; Diarrhea; Diphosphonates; Esophagitis; Estrogen Replacement Therapy; Fractures, Bone; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes; Vitamin D	2014
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate. Journal of endocrinological investigation, 2015, Volume: 38, Issue:8 Topics: Aged; Bone Density; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Retrospective Studies; Thiophenes; Vitamin D	2015
The Impact of Strontium Ranelate on Metaphyseal Bone Healing in Ovariectomized Rats. Calcified tissue international, 2015, Volume: 97, Issue:4 Topics: Animals; Bone Density Conservation Agents; Disease Models, Animal; Female; Fracture Healing; Humans; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Osteotomy; Ovariectomy; Rats; Rats, Sprague-Dawley; Thiophenes; X-Ray Microtomography	2015
Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women. Endocrine, 2016, Volume: 53, Issue:1 Topics: Aged; Blood Pressure; Bone Density; Bone Density Conservation Agents; Calcium; Cardiovascular Diseases; Cholecalciferol; Cholesterol; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prothrombin Time; Risk Factors; Thiophenes; Treatment Outcome	2016
Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. Endokrynologia Polska, 2016, Volume: 67, Issue:2 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Remodeling; Diphosphonates; Drug Therapy, Combination; Female; Humans; Ibandronic Acid; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Osteoprotegerin; RANK Ligand; Thiophenes	2016
Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: data from Arzoxifene Generations Trial. Archives of endocrinology and metabolism, 2016, Volume: 60, Issue:1 Topics: Age Distribution; Aged; Aged, 80 and over; Bone Diseases, Metabolic; Brazil; Calcium; Dietary Supplements; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Spinal Fractures; Thiophenes; Vitamin D	2016
Letter to the Editor: Strontium Ranelate in the Treatment of Osteoporosis: A Possible Mechanism. The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Resorption; Female; Fractures, Bone; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Thiophenes	2016
DRESS syndrome with autoimmune hepatitis from strontium ranelate. Cutis, 2016, Volume: 97, Issue:5 Topics: Administration, Intravenous; Bone Density Conservation Agents; Drug Hypersensitivity Syndrome; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver; Liver Function Tests; Methylprednisolone; Middle Aged; Osteoporosis, Postmenopausal; Skin; Thiophenes; Treatment Outcome	2016
Response to Comment on Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2016, Volume: 31, Issue:11 Topics: Animals; Bone Density Conservation Agents; Fractures, Bone; Humans; Incidence; Mice; Osteogenesis Imperfecta; Osteoporosis, Postmenopausal; Thiophenes	2016
Ten years too long: strontium ranelate, cardiac events, and the European Medicines Agency. BMJ (Clinical research ed.), 2016, Sep-30, Volume: 354 Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Osteoporosis, Postmenopausal; Pharmacovigilance; Thiophenes; Time Factors	2016
Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosis. Rheumatology (Oxford, England), 2008, Volume: 47 Suppl 4 Topics: Aged; Double-Blind Method; Female; Humans; Multicenter Studies as Topic; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes; Treatment Outcome; Uncoupling Agents	2008
Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2009, Volume: 20, Issue:1 Topics: Aged; Bone Density Conservation Agents; Female; Humans; Immunoglobulins, Intravenous; Organometallic Compounds; Osteoporosis, Postmenopausal; Stevens-Johnson Syndrome; Thiophenes	2009
Generalized cutaneous drug eruption due to strontium ranelate. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:3 Topics: Bone Density Conservation Agents; Drug Eruptions; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2009
Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. British journal of clinical pharmacology, 2008, Volume: 66, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Databases, Factual; Drug Hypersensitivity; Family Practice; Female; Gastrointestinal Diseases; Humans; Memory Disorders; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Product Surveillance, Postmarketing; Risk Assessment; Thiophenes; United Kingdom; Venous Thromboembolism	2008
Strontium ranelate for the management of osteoporosis. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2008, Volume: 23, Issue:7 Topics: Aged; Bone Density; Bone Density Conservation Agents; Dietary Supplements; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes	2008
Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women. Rheumatology international, 2009, Volume: 29, Issue:3 Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Female; Homocysteine; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Prospective Studies; Thiophenes	2009
[How to prevent early postmenopausal fracture risk? Proposition of a strategy]. Gynecologie, obstetrique & fertilite, 2009, Volume: 37, Issue:1 Topics: Age Factors; Aged; Bone Density Conservation Agents; Cost-Benefit Analysis; Diphosphonates; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Thiophenes; Treatment Outcome	2009
Strontium ranelate may cause alopecia. BMJ (Clinical research ed.), 2009, Apr-22, Volume: 338 Topics: Aged; Alopecia; Bone Density Conservation Agents; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2009
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Algorithms; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Costs; Epidemiologic Methods; Female; Health Care Costs; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; Quality-Adjusted Life Years; Thiophenes; United Kingdom	2010
Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:2 Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Kyphosis; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Prospective Studies; Quality of Life; Radiography; Risk Factors; Spinal Fractures; Thiophenes; Thorax; Time Factors	2010
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years. Bone, 2010, Volume: 46, Issue:2 Topics: Aged; Bone Density Conservation Agents; Cost-Benefit Analysis; Etidronic Acid; Female; Humans; Models, Statistical; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality-Adjusted Life Years; Risedronic Acid; Thiophenes	2010
Effects of strontium ranelate, raloxifene and misoprostol on bone mineral density in ovariectomized rats. European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 147, Issue:2 Topics: Animals; Bone Density; Bone Density Conservation Agents; Female; Humans; Misoprostol; Organometallic Compounds; Osteoporosis, Postmenopausal; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Thiophenes	2009
Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:7 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Epidemiologic Methods; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; United Kingdom; Venous Thromboembolism	2010
Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:5 Topics: Biopsy; Bone and Bones; Bone Density Conservation Agents; Durapatite; Female; Humans; Ilium; Organometallic Compounds; Osteoporosis, Postmenopausal; Scattering, Small Angle; Spectrometry, X-Ray Emission; Strontium; Thiophenes; X-Ray Diffraction	2010
Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Calcified tissue international, 2010, Volume: 86, Issue:1 Topics: Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Regeneration; Bony Callus; Diaphyses; Disease Models, Animal; Female; Femur; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Ovariectomy; Peptide Fragments; Rats; Rats, Sprague-Dawley; Teriparatide; Thiophenes; Treatment Outcome; Wound Healing; X-Ray Microtomography	2010
The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:6 Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Research Design; Thiophenes	2010
Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction. Age and ageing, 2010, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Dermatitis, Exfoliative; Female; Humans; Morbidity; Organometallic Compounds; Osteoporosis, Postmenopausal; Skin; Thiophenes; Treatment Outcome	2010
Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010, Volume: 25, Issue:4 Topics: Bone Density; Bone Density Conservation Agents; Calcium; Collagen; Elastic Modulus; Female; Humans; Ilium; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes; Vitamin D	2010
Bladder rupture following osteoporotic pubic ramus and sacral insufficiency fractures. Age and ageing, 2010, Volume: 39, Issue:4 Topics: Accidental Falls; Aged, 80 and over; Ergocalciferols; Fecal Incontinence; Female; Fractures, Stress; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Pubic Bone; Radiography; Rupture; Sacrum; Thiophenes; Urinary Bladder; Urinary Tract Infections; Vitamin D	2010
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:3 Topics: Aged; Aged, 80 and over; Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cohort Studies; Cost-Benefit Analysis; Denosumab; Etidronic Acid; Female; Humans; Markov Chains; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Patient Compliance; Quality-Adjusted Life Years; RANK Ligand; Risedronic Acid; Thiophenes	2011
[Strontium ranelate-induced DRESS syndrome]. Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:2 Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteremia; Biopsy; Bone Density Conservation Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Eosinophilia; Female; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Methicillin-Resistant Staphylococcus aureus; Organometallic Compounds; Osteoporosis, Postmenopausal; Prednisone; Skin; Skin Diseases, Vesiculobullous; Staphylococcal Infections; Syndrome; Thiophenes; Vancomycin	2011
[Osteoporosis]. Praxis, 2011, Jul-06, Volume: 100, Issue:14 Topics: Absorptiometry, Photon; Aged; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Calcium; Denosumab; Diphosphonates; Female; Femoral Neck Fractures; Humans; Male; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; RANK Ligand; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Diseases; Teriparatide; Thiophenes; Vitamin D	2011
Strontium does accumulate in bone. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:3 Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2012
Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment. PloS one, 2011, Volume: 6, Issue:8 Topics: Absorptiometry, Photon; Aged; Biopsy; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ilium; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes; Time Factors; Treatment Outcome; X-Ray Microtomography	2011
The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Molecular and cellular biochemistry, 2012, Volume: 359, Issue:1-2 Topics: Bone Resorption; Cell Differentiation; Cells, Cultured; Humans; NF-kappa B; Organometallic Compounds; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; Signal Transduction; Thiophenes	2012
Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Databases, Factual; Diphosphonates; Female; General Practice; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Patient Compliance; Postmenopause; Raloxifene Hydrochloride; Thiophenes; Time Factors; United Kingdom	2012
Sequential osteoporosis treatments. Joint bone spine, 2011, Volume: 78, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Comorbidity; Drug Therapy, Combination; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Patient Compliance; Risk Factors; Severity of Illness Index; Thiophenes	2011
Stevens-Johnson syndrome due to strontium ranelate. Annals of the Academy of Medicine, Singapore, 2011, Volume: 40, Issue:11 Topics: Aged; Bone Density Conservation Agents; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Stevens-Johnson Syndrome; Thiophenes	2011
Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention. Journal of environmental and public health, 2012, Volume: 2012 Topics: Bone and Bones; Bone Density; Bone Density Conservation Agents; Cohort Studies; Diphosphonates; Female; Femur Neck; Fractures, Bone; Hip; Humans; Male; Micronutrients; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Retrospective Studies; Spine; Thiophenes; Treatment Outcome; Vitamin D	2012
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. Reumatismo, 2012, Mar-16, Volume: 64, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Comorbidity; Databases, Factual; Diagnostic Techniques and Procedures; Diphosphonates; Drug Prescriptions; Drug Utilization; Female; Guideline Adherence; Health Services; Health Services Administration; Hip Fractures; Humans; Medical Record Linkage; Osteoporosis, Postmenopausal; Polypharmacy; Practice Guidelines as Topic; Prescriptions; Recurrence; Retrospective Studies; Risk; Risk Factors; Thiophenes; Vitamin D	2012
Alopecia associated with strontium ranelate use in a 62-year-old woman. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:3 Topics: Alopecia; Bone Density Conservation Agents; Drug Eruptions; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2013
Strontium ranelate--a promising therapeutic principle in osteoporosis. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2012, Volume: 26, Issue:2-3 Topics: Bone Density Conservation Agents; Female; Humans; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Radiography; Thiophenes	2012
MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:2 Topics: Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D	2013
Strontium ranelate treatment improves oxidative damage in osteoporotic rat model. Pharmacological reports : PR, 2012, Volume: 64, Issue:2 Topics: Administration, Oral; Animals; Antioxidants; Bone Density Conservation Agents; Catalase; Disease Models, Animal; Drug Administration Schedule; Female; Glutathione Peroxidase; Humans; Kidney; Lipid Peroxidation; Liver; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiophenes	2012
Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism. Calcified tissue international, 2013, Volume: 92, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcifediol; Calcitriol; Calcium; Case-Control Studies; Creatinine; Dietary Supplements; Female; Humans; Hyperparathyroidism, Primary; Ions; Magnesium; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Thiophenes; Time Factors; Vitamin D	2013
Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:4 Topics: Aged; Aged, 80 and over; Alendronate; Algorithms; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cost-Benefit Analysis; Denosumab; Drug Costs; Etidronic Acid; Female; Health Care Costs; Humans; Middle Aged; Models, Econometric; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; RANK Ligand; Risedronic Acid; Risk Assessment; Thiophenes; United Kingdom	2013
Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:7 Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Evaluation, Preclinical; Female; Femur; Humans; Imidazoles; Materials Testing; Orthopedic Fixation Devices; Osseointegration; Osteoporosis, Postmenopausal; Ovariectomy; Prostheses and Implants; Rats; Stress, Mechanical; Thiophenes; Tibia; Titanium; Zoledronic Acid	2013
Strontium and osteoporosis. The journal of the British Menopause Society, 2003, Volume: 9, Issue:1 Topics: Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes	2003
Strontium ranelate--a novel therapy for osteoporosis or a permutation of the same? The New England journal of medicine, 2004, Jan-29, Volume: 350, Issue:5 Topics: Animals; Bone Density; Bone Remodeling; Clinical Trials as Topic; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Placebos; Thiophenes	2004
Postmenopausal osteoporosis and strontium ranelate. The New England journal of medicine, 2004, May-06, Volume: 350, Issue:19 Topics: Bone Density; Bone Remodeling; Calcification, Physiologic; Female; Humans; Organometallic Compounds; Osteomalacia; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes	2004
Postmenopausal osteoporosis and strontium ranelate. The New England journal of medicine, 2004, May-06, Volume: 350, Issue:19 Topics: Data Interpretation, Statistical; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Outcome Assessment, Health Care; Proportional Hazards Models; Survival Analysis; Thiophenes	2004
Modulation of survival in osteoblasts from postmenopausal women. Bone, 2004, Volume: 35, Issue:1 Topics: Aged; Apoptosis; Cell Survival; Cells, Cultured; Estradiol; Estrogens; fas Receptor; Female; Humans; Middle Aged; Osteoblasts; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Tumor Necrosis Factor-alpha	2004
Bone anabolic agents: the unanswered queries. Basic & clinical pharmacology & toxicology, 2004, Volume: 94, Issue:6 Topics: Alendronate; Anabolic Agents; Animals; Bone Resorption; Clinical Trials as Topic; Female; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes	2004
[New medication combines osteo-anabolic and anti-resorptive effects. Double strategy against osteoporosis]. MMW Fortschritte der Medizin, 2004, Apr-01, Volume: 146, Issue:14 Topics: Animals; Bone Density; Bone Resorption; Controlled Clinical Trials as Topic; Double-Blind Method; Female; Hip Fractures; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Placebos; Rats; Spinal Fractures; Thiophenes; Time Factors	2004
Guidelines for the management of postmenopausal osteoporosis for GPs. Australian family physician, 2004, Volume: 33, Issue:11 Topics: Absorptiometry, Photon; Aged; Antihypertensive Agents; Benzothiadiazines; Biomarkers; Bone Diseases, Metabolic; Calcium; Diphosphonates; Diuretics; Drug Therapy, Combination; Estrogen Replacement Therapy; Family Practice; Female; Fractures, Bone; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Risk Factors; Selective Estrogen Receptor Modulators; Sodium Chloride Symporter Inhibitors; Thiophenes; Vitamin D	2004
Strontium ranelate (Fujisawa/Servier). Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:4 Topics: Animals; Bone Resorption; Drug Industry; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2005
Postmenopausal osteoporosis: therapeutic options. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:2 Topics: Age Factors; Anabolic Agents; Animals; Bone Density; Calcium; Contraceptives, Oral; Diphosphonates; Disease Models, Animal; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thiophenes; Vitamin D	2005
[Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]. Ugeskrift for laeger, 2005, Sep-12, Volume: 167, Issue:37 Topics: Aged; Bone Density; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2005
Management of bone health in postmenopausal women. Hormone research, 2005, Volume: 64 Suppl 2 Topics: Accidental Falls; Bone Density; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk; Teriparatide; Thiophenes; Vitamin D	2005
Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Current opinion in rheumatology, 2006, Volume: 18 Suppl 1 Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Development; Bone Resorption; Female; Humans; Mice; Organometallic Compounds; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Rats; Thiophenes	2006
Strontium ranelate: vertebral and non-vertebral fracture risk reduction. Current opinion in rheumatology, 2006, Volume: 18 Suppl 1 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes	2006
[Strontium ranelate and non-vertebral fracture in postmenopausal osteoporosis]. Medicina clinica, 2006, Jul-15, Volume: 127, Issue:7 Topics: Bone Density Conservation Agents; Female; Fractures, Bone; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2006
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2006, Volume: 17, Issue:12 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fractures, Bone; Health Care Costs; Humans; Markov Chains; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Quality-Adjusted Life Years; Risk Factors; Sweden; Thiophenes; Treatment Outcome	2006
[Osteoporosis priority: Reduce the number of fractures]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2 Topics: Absorptiometry, Photon; Age Factors; Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fractures, Bone; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Spinal Fractures; Teriparatide; Thiophenes; Time Factors	2006
Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance. Calcified tissue international, 2007, Volume: 81, Issue:2 Topics: Animals; Apoptosis; Bone and Bones; Bone Density; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Humans; Osteocytes; Osteoporosis, Postmenopausal; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome	2007
Osteoporosis: non-hormonal treatment. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Calcium, Dietary; Denosumab; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Female; Fractures, Bone; Humans; Ibandronic Acid; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Thiophenes; Vitamin D; Women's Health	2007
Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis and rheumatism, 2007, Volume: 56, Issue:10 Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Cytokines; Female; Humans; Mice; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome; Tumor Necrosis Factor-alpha	2007
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Current medical research and opinion, 2007, Volume: 23, Issue:12 Topics: Aged; Aged, 80 and over; Bone Density; Female; Femur Neck; Hip Fractures; Humans; Incidence; Organometallic Compounds; Osteoporosis, Postmenopausal; Radiography; Thiophenes	2007
[Therapeutics issues in osteoporosis]. Medicina clinica, 2007, Dec-01, Volume: 129, Issue:20 Topics: Aged; Bone Remodeling; Bone Resorption; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Spontaneous; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes	2007
Interstitial granulomatous reaction to strontium ranelate. Archives of dermatology, 2008, Volume: 144, Issue:2 Topics: Bone Density Conservation Agents; Female; Granuloma; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Thiophenes	2008
Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:9 Topics: Administration, Oral; Animals; Bone Density; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Probe Microanalysis; Female; Humans; Ilium; Macaca fascicularis; Male; Organometallic Compounds; Osteoporosis, Postmenopausal; Spectrometry, X-Ray Emission; Spectrum Analysis, Raman; Strontium; Thiophenes; Tissue Distribution; Uncoupling Agents; X-Ray Diffraction	1996
LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34). Endocrinology, 1998, Volume: 139, Issue:11 Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Density; Estrogen Antagonists; Female; Humans; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Thiophenes; Tomography, X-Ray Computed	1998